Study Summary
This trial will compare two methods of treating alcohol use disorder to determine which is more effective and cost-effective.
- Alcoholism
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: Baseline to 6-months post-treatment entry
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Medical Management
1 of 2
Quit Genius - Alcohol
1 of 2
Active Control
Experimental Treatment
300 Total Participants · 2 Treatment Groups
Primary Treatment: Quit Genius - Alcohol · No Placebo Group · Phase 3
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are additional participants being sought for this clinical trial?
"Per the data posted on clinicaltrials.gov, this project is actively accepting participants at present. It was initially published on January 1st 2023 and underwent its most recent update on February 17th of that same year." - Anonymous Online Contributor
How many individuals are involved in this research endeavor?
"Affirmative. Clinicaltrials.gov confirms that this medical trial, which was initially published on January 1st 2023, is currently accepting participants. Roughly 300 individuals must be enlisted from a single site." - Anonymous Online Contributor
Has Quit Genius - Alcohol attained FDA authorization?
"Our team at Power assigned Quit Genius - Alcohol a rating of 3, due to the abundant evidence underpinning its efficacy and safety from Phase 3 clinical trials." - Anonymous Online Contributor